openPR Logo
Press release

“Cervilenz Inc. to Present at OneMedForum 2011 – the Finance Conference for Emerging Healthcare and Life Science Companies”

01-14-2011 01:41 PM CET | Health & Medicine

Press release from: CerviLenz

/ PR Agency: BKV
CerviLenz logo

CerviLenz logo

Cervilenz Inc. has been selected to present the company's background, progress and future plans at OneMedForum 2011 in San Francisco, CA. The presentation will take place on Tuesday, January 11, 2011 at 4:10 pm PST at the Sir Francis Drake Hotel.

Cervilenz Inc. is currently introducing its innovative medical device – CerviLenz® – to the obstetrics market with great success. The first and only device of its kind,
CerviLenz is a simple, low cost, disposable medical device that measures vaginal cervical length objectively. A short cervix during pregnancy is the best predictor of preterm birth – a significant public health problem and the leading cause of infant death.

Recently reported evidence that progesterone therapy can reduce the risk of preterm birth in women with a short cervix creates a very large market for cervical length measurements during pregnancy. Obstetricians and midwives need an accurate, immediate way to measure the cervix, and CerviLenz meets that need. It’s quick, easy, and cost effective.

"This is an exciting time for CerviLenz, and we look forward to sharing our company story at OneMedForum,” said Dean Koch, President and CEO. “There couldn’t be a better time for CerviLenz, given the emerging promise of progesterone therapy to prevent preterm birth in women with a short cervix. CerviLenz can help clinicians identify women who may have a short cervix and, therefore, may benefit from therapy or consultation with maternal-fetal medicine specialists. Cervilenz is proud to be part of the solution to this devastating risk to pregnant women.”

Preterm birth affects over 12% of pregnancies in the United States. The Institute of Medicine estimates that the economic cost of preterm birth in the United States is more than $26 billion annually.
# # #

About Cervilenz Inc.
Cervilenz Inc. is the manufacturer and distributor of CerviLenz®, a low cost, single use medical device that measures vaginal cervical length. Dedicated to making a difference in the world of prematurity, Cervilenz Inc. donates a portion of revenue to charitable organizations that advance maternal and fetal health worldwide. The company headquarters is in Chagrin Falls – a suburb of Cleveland, Ohio. For more information, please visit cervilenz.com or contact Melanie Sweeney, Director of Marketing (440.337.4253 or melanie@cervilenz.com).

About the OneMedForum and OneMedPlace
Founded in 2008, OneMedForum events are held biannually in San Francisco in January and in New York in June. They are designed to create a communications platform for emerging companies to connect with strategic partners and investors. OneMedPlace is a virtual community that connects emerging companies seeking capital, distribution, and visibility with investors and strategic partners looking for health and medical innovations to invest in, acquire, license, distribute, purchase or utilize.

100 N. Main Street, Suite 300
Chagrin Falls, OH 44022

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release “Cervilenz Inc. to Present at OneMedForum 2011 – the Finance Conference for Emerging Healthcare and Life Science Companies” here

News-ID: 158287 • Views:

More Releases from CerviLenz

New Data for the CerviLenz® Device Presented at the 10th World Congress of Maternal and Neonatal Health
New Data for the CerviLenz® Device Presented at the 10th World Congress of Mate …
Cleveland, Ohio and Rome, Italy – December 20, 2011 Two new studies demonstrating the clinical utility of the CerviLenz® device were presented today at the 10th World Congress of Maternal and Neonatal Health in Rome, Italy. The CerviLenz device is simple to use and disposable, allowing cervical length measurement in any health care setting and providing an immediate quantitative result. The Congress sponsors include the World Health Organization, the European Association of
Cervilenz Inc. receives CE Mark and Additional International Patents for its Signature CerviLenz® Device
Cervilenz Inc. receives CE Mark and Additional International Patents for its Sig …
CLEVELAND, OH – November 17, 2011 Cervilenz Inc. recently received its CE Mark and ISO 13485 Certification for the CerviLenz® device. This innovative medical device is used to measure vaginal cervical length to help obstetricians identify and manage pregnant women at high risk for premature birth. Cervilenz Inc. also added to its already robust patent portfolio for the device. The company now holds 12 issued patents, including 5 in the United States,
Interplex Medical Exhibit at MEDICA 2011 Features The CerviLenz® Device Used fo …
Milford OH – November 14, 2011 - Interplex Medical, LLC, an FDA-registered, ISO 13485-certified company that designs and manufactures medical products for OEM customers, will display a variety of newly developed components, subsystems and finished products at MEDICA 2011, including an innovative device it helped develop for Cleveland-based Cervilenz Inc. The Interplex Medical exhibit at Medica will be located in the North America Pavilion at Booth D32-13 in
Cervilenz Inc. Exhibits at the 2011 Annual Clinical Meeting
Cervilenz Inc. Exhibits at the 2011 Annual Clinical Meeting
Cervilenz Inc. is exhibiting at the 59th Annual Clinical Meeting (ACM) of The American College of Obstetricians and Gynecologists from May 2nd to May 4th, 2011 in Washington D.C. Cervilenz Inc. can be found at Booth #2528. CerviLenz® measures cervical length during pregnancy. A short cervix is a powerful predictor of preterm birth risk. This simple tool gives obstetricians and midwives a quick, easy way to measure the

All 5 Releases